<DOC>
	<DOCNO>NCT00929825</DOCNO>
	<brief_summary>The transplantation hematopoietic stem cell ( THSC ) therapeutic modality develop treatment various disease leukemia , bone marrow aplasia , lymphoma , multiple myeloma , among others . Most patient undergo THSC usually oral manifestation result immunosuppression achieve chemotherapy and/or radiotherapy . The common complication reduction salivary flow , mucositis graft-versus-host disease ( GVHD ) . These condition debilitate interfere medical therapy , lead systemic complication , affect prognosis increase length hospitalization patient cost treatment . To date , protocol prevents reduction salivary flow minimizes occurrence mucositis GVHD patient . This study aim verify effectiveness treatment two sialogogues ( Hyperboloid TENS [ transcutaneous electrical stimulation ] ) restore flow biochemical composition saliva patient undergo THSC myeloablative non-myeloablative conditionating regime .</brief_summary>
	<brief_title>Therapies Salivary Flux Stimulation Patients Transplanted With Hematopoietic Stem Cells</brief_title>
	<detailed_description>It include sample total 60 patient undergoing hematopoietic stem cell transplantation ( THSC ) Clinical Hospital . Patients randomly divide four group , 15 subject : group I patient use mechanical sialogogue ; group II patient make use electrical sialogogue ( TENS ) ; group III patient make use mechanical sialogogue associate TENS group IV patient receive therapy ( control ) . The project present follow experimental design : 1 . Selection patient subject transplantation hematopoietic stem cell ; 2 . Implementation reference sialometry ; 3 . Institution therapy mechanical electrical sialogogue ; 4 . Clinical examination , assessment occurrence mucositis obtention saliva sample pre- post-THSC ; 5 . Qualitative analysis saliva ( turbidity , viscosity color ) ; 6 . Biochemical analysis saliva ; 7 . Statistical analysis data .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<criteria>Patients submit THSC Clinical Hospital Federal University underwent myeloablative nonmyeloablative conditioning regime Age 16 year Oral mucosa intact first day condition Ability cooperate treatment Cases clinical follow Patients refuse participate Patients ability cooperate treatment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Salivary stimulation</keyword>
	<keyword>Transplantation hematopoietic stem cell</keyword>
	<keyword>Hyperboloid</keyword>
	<keyword>Transcutaneous Electrical Stimulation</keyword>
</DOC>